VNB
TEVA icon

Valley National Bancorp’s Teva Pharmaceuticals TEVA Stock Holding History

Valley National Bancorp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$844K Sell
14,665
-425
-3% -$23.7K 1.03% 24
2014
Q3 		$811K Buy
15,090
+150
+1% +$7.95K 0.94% 27
2014
Q2 		$784K Buy
14,940
+2,475
+20% +$127K 0.92% 32
2014
Q1 		$658K Hold
12,465
– – 0.87% 33
2013
Q4 		$499K Buy
+12,465
New +$491K 0.49% 57

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Valley National Bancorp's TEVA Position: Q4 2014 in Review

Valley National Bancorp reduced its Teva Pharmaceuticals (TEVA) stake by 2.8% in Q4 2014, selling an estimated $23.7K and leaving 14,665 shares worth $844K. The position accounts for 1.03% of the portfolio, ranked #24.

Valley National Bancorp first reported a position in TEVA in Q4 2013 and has held it in 5 quarters since. 822 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

  • Valley National Bancorp held 14,665 shares of Teva Pharmaceuticals worth $844K as of Q4 2014.
  • Valley National Bancorp sold 425 Teva Pharmaceuticals shares in Q4 2014, an estimated $23.7K.
  • Teva Pharmaceuticals made up 1.03% of Valley National Bancorp's portfolio in Q4 2014, its #24 holding.
  • Valley National Bancorp first reported a position in Teva Pharmaceuticals in Q4 2013 and has held it in 5 quarters since.
  • 822 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2014.

Based on Valley National Bancorp's 13F filing for Q4 2014, filed 9 Feb 2015.